BIO-key raises $2.5M through warrant inducement deal
What's the deal? BIO-key InternationalDealroom has a profile for this one. Try Dealroom → (NASDAQ: BKYI) has entered a warrant inducement agreement with an existing institutional investor, expecting to raise about $2.5 million in gross proceeds. Under the deal, the investor will exercise outstanding warrants to buy 618,334 shares of common stock at a reduced exercise price of $4.06 per share.
The mechanics: The warrants being exercised were originally issued on October 28, 2025. In exchange, BIO-key agreed to issue new unregistered warrants to buy 1,236,668 shares, also priced at $4.06.
What's next? The new warrants become exercisable only after stockholder approval under Nasdaq rules and will carry a five-year term from that date. BIO-key plans to file a registration statement with the Securities and Exchange Commission covering the resale of shares issuable upon exercise.
Maxim GroupDealroom has a profile for this one. Try Dealroom → is acting as exclusive placement agent. Gross proceeds are stated before placement agent fees and other offering expenses.
The signal: Warrant inducement deals let smaller listed companies pull forward capital by cutting exercise prices for investors already holding paper. For BIO-key, the structure raises near-term cash while deferring the larger dilution tied to the new warrants until shareholders sign off.
Read more: StreetInsider
Image credit: Long Zheng
